List of works by Ludwig Kappos

10 years of interferon beta-1b (Beta feron therapy

scientific article

2015 Multiple Sclerosis Experts Summit.

scientific article published in December 2015

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

scientific article published on 2 September 2009

3D GRASE arterial spin labelling reveals an inverse correlation of cortical perfusion with the white matter lesion volume in MS.

scientific article published on 30 March 2012

A comparative analysis of Patient-Reported Expanded Disability Status Scale tools

scientific article

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression

scholarly article by Yuri Nakamura et al published 5 September 2018 in Journal of Neuroinflammation

A confusing patient's history: small or large vessel vasculitis?

scientific article published on 23 September 2009

A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients

scientific article

A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up

scientific article published on 20 May 2015

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

scientific article

Abnormal connectivity of the sensorimotor network in patients with MS: A multicenter fMRI study

Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis

scientific article published on 17 August 2009

Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients

scientific article

Altered functional adaptation to attention and working memory tasks with increasing complexity in relapsing‐remitting multiple sclerosis patients ⬇️

scientific article published on November 12, 2010

Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects.

scientific article

Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future?

scientific article

Analysis of impairment related functional architecture in MS patients during performance of different attention tasks

scientific article published in April 2003

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype

scientific article

Antigen Extraction and B Cell Activation Enable Identification of Rare Membrane Antigen Specific Human B Cells

Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF.

scientific article published in February 2007

Assessing response to interferon-β in a multicenter dataset of patients with MS.

scientific article published on 15 June 2016

Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study

scientific article

Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years

scientific article published on 12 August 2019

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b

scientific article

Association of brain volume loss and long-term disability outcomes in patients with multiple sclerosis treated with teriflunomide

scientific article published on 14 June 2019

Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial

scientific article

Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial

scientific article

Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial

scientific article

Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis

scientific article published on December 2003

Automatic Spinal Cord Gray Matter Quantification: A Novel Approach

scientific article published on 22 August 2019

Balance control in multiple sclerosis: correlations of trunk sway during stance and gait tests with disease severity

scientific article published on 5 August 2012

Biplanar MRI for the assessment of the spinal cord in multiple sclerosis

scientific article published on 26 April 2012

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

article by Jens Kuhle et al published 5 March 2019 in Neurology

Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study.

scientific article published on 30 January 2018

Case-Based fMRI Analysis after Cognitive Rehabilitation in MS: A Novel Approach

scientific article

Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis

scientific article published on 22 January 2014

Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis

scientific article published on 27 June 2014

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes

scientific article published on 13 February 2015

Clinical effects of natalizumab on multiple sclerosis appear early in treatment course

scientific article published on 5 January 2013

Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study

scientific article published in September 2013

Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri® Observational Program (TOP)

scientific article published on 14 May 2020

Clinical trials in multiple sclerosis

scientific article published on January 2014

Cocapture of cognate and bystander antigens can activate autoreactive B cells

scientific article published on 05 January 2017

Cognitive rehabilitation of working memory in juvenile multiple sclerosis-effects on cognitive functioning, functional MRI and network related connectivity

scientific article published on 2 April 2015

Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PML

scientific article published on 03 December 2020

Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years

scientific article

Comparative efficacy of switching to natalizumab in active multiple sclerosis

scientific article

Comparison between balanced steady-state free precession and standard spoiled gradient echo magnetization transfer ratio imaging in multiple sclerosis: methodical and clinical considerations

scientific article published on 20 December 2014

Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study.

scientific article published on 13 May 2011

Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial

scientific article published on 4 December 2011

Competing interests in multiple sclerosis research.

scientific article published in January 2003

Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosis

scientific article published on 19 June 2017

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

scientific article published on 08 June 2020

Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.

scientific article published on 4 March 2013

Copeptin: a novel, independent prognostic marker in patients with ischemic stroke

scientific article published in December 2009

Correction: Prognostic implications of a carefully performed neurological assessment in patients with a first event suggestive of multiple sclerosis.

scientific article published on 4 February 2011

Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis

scientific article

DACLIZUMAB HYP VS IM INTERFERON BETA-1A IN MS: NEDA RESULTS FROM DECIDE

scientific article published on 15 November 2016

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis

scientific article published on October 2015

Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.

scientific article published on 13 July 2016

Defining the clinical course of multiple sclerosis: the 2013 revisions

scientific article

Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience

scientific article

Delayed-release dimethyl fumarate and disability assessed by the Multiple Sclerosis Functional Composite: Integrated analysis of DEFINE and CONFIRM.

scientific article

Detection of cerebrospinal fluid leaks by intrathecal contrast-enhanced magnetic resonance myelography.

scientific article published in December 2013

Determinants of iron accumulation in deep grey matter of multiple sclerosis patients

scientific article published on 30 April 2014

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

scientific article published on 21 December 2017

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

scientific article

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

scientific article

Dimethyl fumarate for multiple sclerosis.

scientific article

Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis

scientific article

Disability progression in relapse-free multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetate

scientific article published on 28 May 2020

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

scientific article

Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study

scientific article

Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials.

scientific article published in March 2018

Effect of drugs in secondary disease progression in patients with multiple sclerosis

scientific article published in June 2004

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

scientific article

Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis--a longitudinal MRI study

scientific article published on 16 February 2010

Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial

scientific article published in 2023

Effects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies

scientific article published on 12 October 2014

Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study

scientific article

Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis

scientific article published on 4 April 2012

Efficacy and Safety of Fingolimod in an Unselected Patient Population

scientific article

Efficacy and safety of interferon beta-1b sc in older RRMS patients—a posthoc analysis of the BEYOND study

article

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

scientific article published in October 2008

Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes

scientific article

Endonasal surgery for contact point headaches: a 10-year longitudinal study

scientific article

Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP)

scientific article published on 15 January 2016

Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis

scientific article

Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial

Evidence for acute neurotoxicity after chemotherapy

scientific article published on December 2010

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients

scientific article published on 15 September 2015

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

scientific article (publication date: 7 July 2015)

Extraocular blood flow and endothelin-1 plasma levels in patients with multiple sclerosis

scientific article published in January 2003

Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15.

scientific article

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis

scientific article published on 25 March 2015

Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.

scientific article published on 14 March 2018

Fingolimod for multiple sclerosis: mechanism of action, clinical outcomes, and future directions

scientific article published on October 2011

Fingolimod in relapsing multiple sclerosis: An integrated analysis of safety findings

scientific article published on 25 March 2014

First-dose effects of fingolimod: Pooled safety data from three phase 3 studies

scientific article

Five-years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension

scientific article published on 20 July 2020

Fluid biomarker and electrophysiological outcome measures for progressive MS trials

scientific article published in October 2017

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

scientific journal article

Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene

scientific article

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

scientific article

Genomics and proteomics: role in the management of multiple sclerosis

scientific article

Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration

scientific article published on 04 September 2013

Glutamate gene polymorphisms predict brain volumes in multiple sclerosis

scientific article published on 31 July 2012

Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study

scientific article published on May 2017

Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability

article by Stefan D Roosendaal et al published 17 May 2011 in Multiple Sclerosis Journal

Health-related quality of life in multiple sclerosis: effects of natalizumab

scientific article

Histone deacetylase gene variants predict brain volume changes in multiple sclerosis

scientific article published on 11 August 2012

Homing frequency of human T cells inferred from peripheral blood depletion kinetics after sphingosine-1-phosphate receptor blockade

scientific article

Images in clinical medicine. Dissociation of voluntary and emotional innervation after stroke

scientific article published in October 2010

Immune-mediated neuropathies: etiology and pathogenic relationship to aging processes

scientific article

Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS.

scientific article

Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis

scientific article published on October 2012

Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study

scientific article

Improved characterization of visual evoked potentials in multiple sclerosis by topographic analysis

scientific article published on 02 October 2013

Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial

scientific article published on 13 May 2016

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases

scientific article

Individual Assessment of Brain Tissue Changes in MS and the Effect of Focal Lesions on Short-Term Focal Atrophy Development in MS: A Voxel-Guided Morphometry Study

scientific article published on April 2016

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

article

Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis

scientific article published on December 2016

Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome

scientific article published on 10 July 2013

Interferon-beta antibodies: implications for the treatment of MS.

scientific article

Interferons in multiple sclerosis

scientific article

Interleukin 17F level and interferon β response in patients with multiple sclerosis

scientific article

Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: the impact of thalamic subnuclei on disability

scientific article

Lack of association between antimyelin antibodies and progression to multiple sclerosis

scientific article

Laminar analysis of the cerebellar cortex shows widespread damage in early MS patients: A pilot study at 7T MRI

scientific article published on 23 October 2020

Laquinimod Safety Profile: Pooled Analyses from the ALLEGRO and BRAVO Trials

scientific article published on January 2017

Learning ability correlates with brain atrophy and disability progression in RRMS

scientific article published on 15 October 2018

Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis

scientific article

Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis

scientific article published on 11 July 2013

Letter Re: Retraction: Risedronate Therapy For Prevention Of Hip Fracture After Stroke In Elderly Women; Risedronate Therapy For Prevention Of Hip Fracture After Stroke In Elderly Women: Reply From The Authors

scientific article published in January 2017

Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

scientific article published on 25 June 2015

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

scientific article

Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study

scientific article

Long-term effects of fingolimod in multiple sclerosis: the randomized FREEDOMS extension trial

scientific article published on 20 March 2015

Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial

scientific article published on 29 October 2020

Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study★★

scientific article published on 24 May 2019

Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis

scientific article published on 4 September 2015

Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study

scientific article

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study

scientific article published on 10 February 2016

Longitudinal gray matter changes in multiple sclerosis--differential scanner and overall disease-related effects

scientific article published on 29 April 2011

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

scientific article published on 24 February 2020

MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome

scientific article

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

scientific article published on 25 January 2016

MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials

scientific article published on 06 December 2011

MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis

scientific article

MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study

scientific article

Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results

scientific article published on September 2007

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

scientific article published on 27 February 2013

Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study

scientific article published in November 2009

Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis

scientific article

Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study

scientific article

Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients

scientific article (publication date: 2011)

Measuring and Validating the Levels of Brain-Derived Neurotrophic Factor in Human Serum.

scientific article

Mental health problems in children of somatically ill parents, e.g. multiple sclerosis.

scientific article published on 29 November 2006

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

scientific article

MiR-126: a novel route for natalizumab action?

scientific article published on 5 March 2014

Mitochondrial cytopathy with common MELAS mutation presenting as multiple system atrophy mimic

scientific article

Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data

scientific article

Molecular mechanism underlying the impact of vitamin D on disease activity of MS.

scientific article

Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice

scientific article published on 31 July 2013

Multicenter R2* mapping in the healthy brain

scientific article published in March 2014

Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.

scientific article

Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studies

scientific article published on 17 February 2016

Multivariate pattern classification of gray matter pathology in multiple sclerosis

scientific article published on 5 January 2012

Natalizumab therapy for multiple sclerosis

scientific article published in February 2013

Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring

scientific article

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

scientific article (publication date: August 2011)

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting

scientific article published on 02 May 2018

Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development

scientific article published on 31 March 2016

Natalizumab: targeting alpha4-integrins in multiple sclerosis

scientific article published on January 2008

Neurofilament light levels are associated with long-term outcomes in multiple sclerosis

scientific article published on 04 November 2019

Neurofilaments as biomarkers in neurological disorders

article by Michael Khalil et al published 31 August 2018 in Nature Reviews Neurology

Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study

scientific article published on 30 June 2016

Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report

scientific article published on 24 April 2007

Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial

scientific article published on 27 September 2011

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

scientific article

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a.

scientific article published in January 2018

No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study

scientific article published in December 2016

Non-communicating syringomyelia: a feature of spinal cord involvement in multiple sclerosis

Nonconventional MRI and microstructural cerebral changes in multiple sclerosis.

scientific article

Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis

Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis

scientific article published in April 2017

Ocrelizumab in relapsing and primary progressive multiple sclerosis: pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO

scientific article published on 17 November 2020

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

scientific article

Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies

scientific article published on 28 January 2019

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

scientific article published on 21 December 2016

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

scientific article published on 21 December 2016

Oculopharyngeal muscular dystrophy - an under-diagnosed disorder?

scientific article

Ofatumumab versus Teriflunomide in Multiple Sclerosis

scientific article published on 01 August 2020

On the origin of Neurostatus.

scientific article published on 11 April 2015

Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis

scientific article published on 8 December 2015

Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine

scientific article published in April 2005

Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction

scientific article published on 19 June 2015

Oral fingolimod (FTY720) for relapsing multiple sclerosis

scientific article

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

scientific article

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

scientific article

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 2 September 2014

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 23 January 2014

PARP-1 deregulation in multiple sclerosis

scientific article published on 01 October 2019

PML risk and natalizumab: the elephant in the room

scientific article

PML with dimethyl fumarate-No convincing case against natalizumab

scientific article published on 22 August 2019

Pathway and network-based analysis of genome-wide association studies in multiple sclerosis

scientific article published on 13 March 2009

Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study

scientific article published on 12 January 2014

Performance of five research-domain automated WM lesion segmentation methods in a multi-center MS study.

scientific article published on 9 September 2017

Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies

scientific article published on 10 April 2007

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis

scientific article

Placebo-controlled trial of oral laquinimod for multiple sclerosis

scientific article

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

scientific article published on 12 September 2013

Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions

scientific article

Power estimation for non-standardized multisite studies

scientific article

Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis

scientific article published on 21 June 2012

Predicting PML in natalizumab-treated patients: can we do better?

scientific article published on 20 April 2013

Predictors of disease activity in 857 patients with MS treated with interferon beta-1b

scientific article

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy

Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis

scientific article published on 24 January 2014

Preserved antigen-specific immune response in patients with multiple sclerosis responding to IFNβ-therapy

scientific article

Prognostic factors for long-term outcomes in relapsing-remitting multiple sclerosis

scientific article

Progression in disability and regional grey matter atrophy in relapsing–remitting multiple sclerosis

scientific article published on 26 June 2013

Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study

scientific article

Quantified CSF antibody reactivity against myelin in multiple sclerosis

scientific article published on 9 November 2015

Quantifying progression of multiple sclerosis via classification of depth videos

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations

scientific article published in February 2018

Randomized trial of oral teriflunomide for relapsing multiple sclerosis

scientific article published in October 2011

Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis

scientific article published on 30 January 2015

Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice

scientific article

Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational Program

scientific article published on 24 June 2020

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

scientific article published on 10 April 2012

Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-related Hospitalizations: Integrated Analysis of the Delayed-release Dimethyl Fumarate Phase III Studies

scientific article published on 30 October 2015

Relation between functional brain imaging, cognitive impairment and cognitive rehabilitation in patients with multiple sclerosis

scientific article

Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients

scientific article

Reliability and acceptance of dreaMS, a software application for people with multiple sclerosis: a feasibility study

scientific article published in 2022

Reply

Retraining attention in MS.

scientific article

Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients

scientific article published on 15 September 2017

Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab

scientific article published on February 2012

Réduction à long-terme du taux de poussées et de progression du handicap après 6 ans de traitement par ocrelizumab (OCR) chez des patients atteints de sclérose en plaques récurrente (SEP-R)

scientific article published on 01 September 2020

SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts

scientific article published in August 2017

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study

scientific article published on 05 July 2016

Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial

scientific article published on 16 August 2016

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

scientific article

Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies

scientific article published on 11 May 2016

Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis

scientific article

Screening for balance disorders in mildly affected multiple sclerosis patients

scientific article

Secondary progressive multiple sclerosis: current knowledge and future challenges

scientific article

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis

scientific article published on 16 May 2017

Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis

article by Nelly Siller et al published 15 March 2018 in Multiple Sclerosis Journal

Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome

scientific article published on 16 June 2014

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome

scientific article published on 25 February 2015

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy

scientific article published on 9 March 2016

Short-term and long-term safety and tolerability of interferon β-1b in multiple sclerosis

scientific article

Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis

scientific article published on 06 July 2018

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

scientific article published on 11 June 2013

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.

scientific article published on 22 March 2018

Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis

scientific article published on 18 November 2020

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions

scientific article published on 19 December 2018

Sodium intake and multiple sclerosis activity and progression in BENEFIT.

scientific article published on 26 May 2017

Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis

scientific article

Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis

scientific article published in October 2010

Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials

Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST).

scientific article

Subcutaneous interferon β-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study

scientific article published on 30 December 2016

Survey of diagnostic and treatment practices for multiple sclerosis in Europe, part 2: progressive MS, paediatric MS, pregnancy and general management

scientific article published on 21 January 2018

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS

scientific article published on 29 May 2015

T-cell response against varicella-zoster virus in fingolimod-treated MS patients

scientific article published on 22 May 2013

Teriflunomide for oral therapy in multiple sclerosis

scientific article

Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.

scientific article published on 14 July 2013

Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study

scientific article

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.

scientific article

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

scientific article published on 10 August 2016

The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis

scientific article published on 01 January 2020

The Janus face of CNS-directed autoimmune response: a therapeutic challenge

scientific article published in November 2002

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options

scientific article

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

scientific article published on 9 March 2018

The distribution of magnetic resonance imaging response to interferonβ–1b in multiple sclerosis

article

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

scientific article published on 21 July 2015

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

scientific article published on 29 May 2009

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.

scientific article published on 18 March 2009

The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies.

scientific article

The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges

scientific article published on 16 June 2020

The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients

scientific article published on 19 August 2013

The role of cerebellar abnormalities in neuromyelitis optica--a comparison with multiple sclerosis and healthy controls

scientific article published on 5 December 2014

The role of the cerebellum in multiple sclerosis-150 years after Charcot.

scientific article published on 23 February 2018

Therapy-induced plasticity of cognitive functions in MS patients: insights from fMRI.

scientific article

Tolérance d’ocrelizumab (OCR) : analyse actualisée des données de tolérance des patients atteints de sclérose en plaques récurrente (SEP-R) et de sclérose en plaques primaire progressive (SEP-PP)

scientific article published on 01 September 2020

Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment

scientific article published on November 2006

Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis

scientific article published on September 2017

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge

scientific article published on 26 December 2018

Usability and Acceptability of ASSESS MS: Assessment of Motor Dysfunction in Multiple Sclerosis Using Depth-Sensing Computer Vision.

scientific article published on 24 June 2015

Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies

scientific article published on 15 June 2012

Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management

scientific article

Vitamin D as an early predictor of multiple sclerosis activity and progression

scientific article published on March 2014

What is new in MS spasticity research? Poster session highlights

scientific article

White matter lesion filling improves the accuracy of cortical thickness measurements in multiple sclerosis patients: a longitudinal study

scientific article

White matter lesion location correlates with disability in relapsing multiple sclerosis

scientific article published on 01 January 2020

Working memory training in patients with multiple sclerosis - comparison of two different training schedules.

scientific article published in January 2009

α4-integrin receptor desaturation and disease activity return after natalizumab cessation

scientific article

Paulina is supported by:

About Paulina

Help